Oligodendrocytes are coupled by gap junctions (GJs) formed mainly by connexin47 (Cx47) and Cx32. Recessive GJC2/Cx47 mutations cause Pelizaeus-Merzbacher-like disease, a hypomyelinating leukodystrophy, while GJB1/Cx32 mutations cause neuropathy and chronic or acute-transient encephalopathy syndromes. Cx32/Cx47 double knockout (Cx32/Cx47dKO) mice develop severe CNS demyelination beginning at 1 month of age leading to death within weeks, offering a relevant model to study disease mechanisms. In order to clarify whether the loss of oligodendrocyte connexins has cell autonomous effects, we generated transgenic mice expressing the wild-type human Cx32 under the control of the mouse proteolipid protein promoter, obtaining exogenous hCx32 expression in oligodendrocytes. By crossing these mice with Cx32KO mice, we obtained expression of hCx32 on Cx32KO background. Immunohistochemical and immunoblot analysis confirmed strong CNS expression of hCx32 specifically in oligodendrocytes and correct localization forming GJs at cell bodies and along the myelin sheath. TG + Cx32/ Cx47dKO mice generated by further crossing with Cx47KO mice showed that transgenic expression of hCx32 rescued the severe early phenotype of CNS demyelination in Cx32/Cx47dKO mice, resulting in marked improvement of behavioral abnormalities at 1 month of age, and preventing the early mortality. Furthermore, TG + Cx32/Cx47dKO mice showed significant improvement of myelination compared with Cx32/Cx47dKO CNS at 1 month of age, while the inflammatory and astrogliotic changes were fully reversed. Our study confirms that loss of oligodendrocyte GJs has cell autonomous effects and that re-establishment of GJ connectivity by replacement of least one GJ protein provides correction of the leukodystrophy phenotype.
Introduction
Connectivity through gap junctions (GJs) mediates inter-and intracellular communication that is vital for myelinating cells. GJC2/Cx47 mutations cause a hypomyelinating leukodystrophy known as Pelizaeus-Merzbacher-like disease (PMLD) (1) while GJB1/Cx32 mutations cause X-linked Charcot-Marie-Tooth (CMT1X), a peripheral neuropathy that may be accompanied by chronic or acute-transient encephalopathy syndromes, often induced by conditions of metabolic stress (2) (3) (4) . Accumulating evidence indicates that GJC2/Cx47 mutations (5), as well as most GJB1/Cx32 mutations (6,7) result in loss of function, suggesting that strategies to replace connexin function in oligodendrocytes may be a promising future therapeutic strategy.
Oligodendrocytes express at least three different GJ proteins, Cx29, Cx32 and Cx47 (8) (9) (10) . Cx47 is found in perikarya and proximal processes of all oligodendrocytes (11) (12) (13) forming homotypic oligodendrocyte-oligodendrocyte (O/O) or heterotypic oligodendrocyte-astrocyte (O/A) GJs with Cx43 as astrocytic partner (10, (14) (15) (16) . Cx32 is mainly expressed along large myelinated fibers of the white matter (WM) (8, 11) forming intracellular GJs within the myelin sheath but also in cell bodies of mainly gray matter oligodendrocytes forming O/A GJs with Cx30 as astrocytic partner (9, 10, 14, 17) . Cx29 and its human ortholog Cx31.3 appear to mainly form hemichannels along thin myelinated fibers (11, 18, 19) .
Mice lacking Cx32 or Cx47 develop minimal CNS pathology and no obvious CNS phenotype indicating that these proteins have partially overlapping functions. However, loss of both oligodendrocyte connexins in Cx32/Cx47 double knockout (Cx32/ Cx47dKO) mice leads to severe and early CNS demyelination (12, 13) . Cx32/Cx47dKO mice develop a progressive, coarse action tremor during the third postnatal week followed by tonic seizures, which increase in frequency and severity until the animals die, typically during the sixth postnatal week. At 1 month of age, these mice show severe CNS demyelination, axonal degeneration and apoptosis of oligodendrocytes in the spinal cord funiculi and in the optic nerves, confirming that GJ connectivity is vital for oligodendrocytes (12, 13) .
Transgenic replacement of Cx32 expression in Schwann cells of Cx32KO mice resulted in full rescue of the peripheral neuropathy, confirming the cell autonomous mechanisms in CMT1X (20) . Such cell autonomous effect needs to be shown also for CNS pathology resulting from connexin mutations, given the more complex cell-cell interactions and restricted compatibilities between glial connexins (10, 15, 16) . For this purpose we generated transgenic mice expressing the wild-type (WT) human Cx32 under the control of the mouse proteolipid protein (Plp) promoter, obtaining exogenous hCx32 expression in oligodendrocytes. Transgenic expression of hCx32 in Cx32/Cx47dKO mice resulted in almost complete rescue of behavioral abnormalities at 1 month of age, and prevented the severe CNS demyelination and early mortality. Oligodendrocyte GJ connectivity was re-established through homotypic Cx32 and heterotypic Cx32/ Cx30 channels.
Results
Generation of TG + Cx32KO and TG + Cx32/Cx47dKO mice Successful pronuclear injection of the transgenic construct ( Fig. 1A) and screening of offspring revealed five transgenic founders. Two of the founders showed stable transmission to the next generation and were crossed with Cx32KO mice and further genotyped (Fig. 1B) . About 30% of the mice carried the transgene (TG + ). These mice were crucial for the assessment of the transgenic expression and exogenous Cx32 localization on a Gjb1-null/Cx32KO background. Therefore, these two lines were further expanded on Cx32KO background.
Expression of hCx32 in the CNS and PNS of Cx32KO mice and rescue of the peripheral neuropathy
We compared the expression levels of exogenous hCx32 from brain and spinal cord tissues of TG + Cx32KO to the endogenous expression in WT mice at 1 month of age by reverse transcriptasepolymerase chain reaction (RT-PCR). cDNA was amplified using primers which are identical in both human and mouse Cx32, resulting in a 553bp product. Restriction digest with enzymes specific for the human or the mouse Cx32 showed that tissues from transgenic mice had 2 to 3-fold higher levels of Cx32 mRNA than the WT tissues (Fig. 1C) . Accordingly, immunoblot analysis showed higher levels of Cx32 protein in TG + Cx32KO spinal cord compared with WT spinal cord. However, sciatic nerves from transgenic mice showed slightly lower Cx32 levels compared with WT nerves. Cx32 expression was absent in TG + Cx32KO liver and in all Cx32 KO control tissues (Fig. 1D ). Both TG + Cx32KO transgenic lines showed similar expression at the RNA and protein level (data not shown) and only one was expanded for further analysis and crossing into Cx47KO background.
To assess the transgenic expression of Cx32 in oligodendrocytes of Cx32KO mice, we immunostained different CNS areas including the spinal cord, cerebellum and cerebrum with Cx32 antibody combined with cell markers for oligodendrocytes (CC-1), astrocytes (GFAP), neurons (NeuN) and microglial cells (IbaI) (Fig. 2) . In the spinal cord ( Fig. 2A-C ) Cx32 was localized mainly along large myelinated fibers in WT mice and formed GJ-like plaques only around oligodendrocyte cell bodies in the gray matter, while in TG + Cx32KO mice Cx32 was expressed around oligodendrocyte cell bodies not only in the gray but also in the WM, in addition to myelinated fibers. In the cerebrum at the level of the hippocampus ( Fig. 2D-F ) Cx32 was localized in deep neocortex of WT mice along myelinated fibers, adjacent but not within the corpus callosum (CC), whereas in the TG + Cx32KO Cx32 was localized additionally in CC along small diameter fibers and around oligodendrocyte cell bodies (Fig. 2E ).
In the cerebellum (Fig. 2G-I ) of WT mice Cx32 was mainly expressed in WM fibers, while TG + Cx32KO mice also showed Cx32 immunoreactivity in the granule cell layer. No specific Cx32 staining was detected in any Cx32KO tissues. Transgenic Cx32 expression was restricted to oligodendrocytes and was not detected in GFAP-positive astrocytes, NeuN-positive neurons or Iba1-positive microglial cells (Fig. 2J-L) .
Given the immunoblot results we also examined Cx32 expression in Schwann cells by immunostaining sciatic nerve teased fibers ( Fig. 3A-C) . Cx32 was expressed and normally localized at non-compact myelin areas in TG + Cx32KO nerves similar to the WT nerve, while it was absent from Cx32KO fibers. To further verify that hCx32 expression in Cx32KO Schwann cells can rescue the development of peripheral neuropathy starting after 3 month of age (21, 22) , we examined semithin sciatic nerve sections from groups of 8-month-old mice (n = 4 per genotype) with morphometric analysis of abnormally myelinated fibers as previously described (7) . TG + Cx32KO mice showed significantly lower rates of abnormally myelinated fibers compared with Cx32KO littermates (P = 0.0023), confirming that Plp promoterdriven Cx32 expression can rescue the peripheral neuropathy in Cx32KO mice (Fig. 3D-F) as was shown previously with P0 promoter-driven expression (20) . These results show that the 11 kb Plp promoter efficiently drives expression of hCx32 in all oligodendrocytes, even in subpopulations normally not expressing Cx32 (11) , and interestingly, also in myelinated (Fig. 1E) .
For behavioral analysis mice were subjected to foot print test (n = 6 per genotype), foot slip test (n = 8), and rotarod test (n = 9). All parameters of foot print analysis, including stride length for all limbs and overlap width, were significantly improved in TG + Cx32/Cx47dKO compared with Cx32/Cx47dKO mice, and reached similar levels as those of the WT animals ( Fig. 4A-C) . Furthermore, the foot slip test revealed that TG + Cx32/Cx47dKO mice had an average of 1 ± 0.5 missteps whereas Cx32/Cx47dKO mice had an average of 9 ± 1.8 missteps (P = 0.0048) (Fig. 4D) . Finally, TG + Cx32/Cx47dKO showed significant improvement in time spent on the rotarod at different speeds compared with Cx32/Cx47dKO mice, although they did not reach the performance of WT and Cx47KO mice (Fig. 4E) . Taking into consideration all behavioral results, TG + Cx32/Cx47dKO mice outperformed Cx32/Cx47dKO animals in their ability for motor coordination and balance.
Kaplan-Meier analysis of the survival rates showed that Cx32/ Cx47dKO mice (n = 11) began to die from the fourth week of age and <20% survived beyond the sixth week, while all mice died by 12 weeks. In contrast, TG + Cx32KO/Cx47dKO mice (n = 14) showed survival rates of up to 47 weeks (maximum observation) with only one mouse that died without previous signs of encephalopathy (P < 0.0001) (Fig. 4F) Cx32/Cx47dKO mice, we examined by immunostaining at 1 month of age the degree of myelination, inflammation and astrogliosis in sections of the cerebrum, cerebellum, spinal cord and optic nerves from TG + Cx32/Cx47dKO and Cx32/Cx47dKO mice. Tissues were stained for myelin oligodendrocyte glycoprotein (MOG), a myelin marker and CD68, a macrophage marker. Numerous CD68 positive macrophages were detected in the spinal cord and optic nerves of Cx32/Cx47dKO mice whereas in the transgenic mice no macrophages were present. Furthermore, myelin immunoreactivity was reduced in Cx32/Cx47dKO mice but appeared normal in TG + Cx32/Cx47dKO tissues ( Fig. 5A-D) . Further staining for astrocytes with GFAP and microglia with Iba1 revealed increased activation of microglia in Cx32/Cx47dKO optic nerve along with increased GFAP immunoreactivity indicating astrogliosis, while these abnormalities were not seen in TG + Cx32/Cx47dKO (Fig. 5E-F) . Similar rescue of myelin pathology, inflammation and astrogliosis was seen in other tissues such as spinal cord and brain (not shown). Further double labeling for oligodendrocytes with CC1 and caspase-3 revealed that many oligodendrocytes in Cx32/Cx47dKO optic nerve and spinal cord were positive for this apoptotic marker, in contrast to TG + Cx32/ Cx47dKO showing no caspase-3 immunoreactivity (Fig. 5G-H) .
Quantification of the optic nerve area covered with Iba1 as well as GFAP immunoreactivity in each group (n = 3 per genotype) confirmed the significant decrease of microglia activation (P = 0.0206) and astrogliosis (P = 0.0319) in TG + Cx32/Cx47dKO compared with Cx32/Cx47dKO mice (Fig. 5I) . Counts of caspase-3 immunoreactive optic nerve oligodendrocytes were on average 27% in the Cx32/Cx47dKO group, and <1% in TG + Cx32/ Cx47dKO, confirming that hCx32 expression also prevented oligodendrocyte apoptosis (Fig. 5J ). Total oligodendrocyte numbers were not significantly different among the two groups at the age of 1 month (data not shown). In addition to the immunostaining results, we assessed the levels of myelin proteins by quantitative immunoblot analysis in spinal cord lysates from each group (n = 3 per genotype) including MOG and myelin basic protein (MBP). This analysis confirmed that both the MOG as well as the MBP levels were significantly higher in TG + Cx32/ Cx47dKO compared with Cx32/Cx47dKO mice (P = 0.014 and P = 0.0334, respectively) ( (Fig. 2) .
Double staining of Cx32 with astrocytic Cx30, known to partner with Cx32 (15) showed that Cx30 was diffusely expressed mostly in the gray matter forming GJ-like plaques, which colocalized with Cx32 GJ plaques around oligodendrocytes in TG + Cx32/ Cx47dKO similar to Cx47KO mice. In contrast, Cx30 showed no colocalization with oligodendrocytes in Cx32/Cx47dKO mice in which Cx32 was absent ( Fig. 7A-C ). Double staining with Cx43 showed the typical expression of Cx43 forming diffuse GJ plaques in gray matter with weak colocalization with Cx32 GJ plaques around oligodendrocytes in TG + Cx32/Cx47dKO and even less in Cx47KO mice. Cx32/Cx47dKO mice showed stronger Cx43 immunoreactivity in gray matter areas, likely reflecting astrogliosis, with absence of Cx32 ( Fig. 7D-F ). Cx29 was normally localized along thinly myelinated fibers in the spinal cord gray matter, in the cerebellum and in the cerebrum in all three genotypes without apparent differences. Cx32 was expressed along medium and large myelinated fibers mostly without colocalization with Cx29 in TG + Cx32/Cx47dKO and Cx47KO mice, while it was absent in Cx32/Cx47dKO (Fig. 7G-I ).
Counts of GJ plaques surrounding oligodendrocytes in confocal images of spinal cord gray matter revealed similar numbers of Cx30 GJ plaques in all genotypes, while Cx32 GJ plaques were increased in TG + Cx32/Cx47dKO compared with Cx47KO mice and showed higher overlap ratios with Cx30 GJ plaques (Fig. 7J) . Counts of Cx43 plaques were significantly increased in Cx32/ Cx47dKO compared with TG + Cx32/Cx47dKO or Cx47KO mice, likely reflecting astrogliosis. Also with this double labeling Cx32 GJ plaques showed higher counts in transgenic compared with Cx47KO mice, as well as increasing overlap with Cx43 (Fig. 7K) . However, Cx32 GJ plaques around TG + Cx32/Cx47dKO oligodendrocytes showed significantly lower overlap levels with Cx43 than with Cx30 (P < 0.0001), indicating that transgenically expressed Cx32 forms O/A GJs mainly through coupling with Cx30. Transgenic expression of Cx32 was also examined in different WM areas of TG + Cx32/Cx47dKO compared with Cx32/Cx47dKO and Cx47KO mice, including the spinal cord WM, cerebellum, optic nerve and cerebrum at the CC level. In the spinal cord and cerebellar WM of TG + Cx32/Cx47dKO and Cx47KO mice Cx32 was expressed along large diameter myelinated fibers, but TG + Cx32/Cx47dKO mice additionally showed Cx32 GJ plaques at oligodendrocyte cell bodies. Cx32 did not colocalize with Cx43 GJ plaques that were diffusely present in all WM areas (Supplementary Material, Fig. S1A-C) . While Cx47KO mice showed the expected mutually exclusive expression of Cx29 along thin fibers and of Cx32 along large fibers (8), in TG + Cx32/Cx47dKO
there was some expression of Cx32 also along thin fibers colocalizing with Cx29 (Supplementary Material, Fig. S1D-F) . Similar expression pattern was found in cerebellum, in which Cx32 formed GJ plaques in WM fibers in both Cx47KO and TG + Cx32/Cx47dKO mice, but in addition there was expression along thin fibers of the molecular layer only in the TG+ (Supplementary Material, Fig. S1G-L) . In WM areas were Cx32 is not physiologically expressed, including the optic nerve and CC (11), Cx47KO showed no Cx32 expression, while TG + Cx32/Cx47dKO
showed Cx32 forming GJ plaques at oligodendrocyte cell bodies with partial colocalization with Cx43, as well as along thinly myelinated fibers colocalizing with Cx29. In Cx47KO and Cx32/ Cx47dKO optic nerve and CC Cx32 was absent (Supplementary Material, Fig. S1M -R; and data not shown).
In conclusion, these findings suggest that transgenic expression of hCx32 in GJ-deficient oligodendrocytes of Cx32/Cx47dKO leads to strong GJ formation along the myelinated fibers, with some ectopic expression along thin fibers as well, as well as reestablishment of O/A heterotypic connections mainly between Cx32 and Cx30 in the GM, and in the WM also by homotypic O/O GJs, similar to the connectivity in Cx47KO CNS. However, Cx32 does not appear to be able to replace Cx47 in O/A connections with Cx43.
Discussion
Phenotypic and pathological rescue of the Cx32/Cx47dKO mice
We have successfully generated transgenic lines strongly expressing hCx32 specifically in oligodendrocytes throughout the CNS, as confirmed by our expression analysis on Cx32KO background. Reestablishment of GJ connectivity in oligodendrocytes rescued the severe phenotype of early CNS demyelination and death in Cx32/Cx47dKO mice. Furthermore, expression of Cx32 in Schwann cells prevented the peripheral neuropathy in Cx32KO mice, confirming that connexin loss in both central and peripheral myelinating cells causes disease through cell autonomous effects.
The Plp promoter has been shown to drive expression specifically in oligodendrocytes (23) (24) (25) . Interestingly, our results confirm that the Plp promoter is also active in Schwann cells, although at lower levels compared with oligodendrocytes, as also reported in previous studies. Our transgene expression levels in the CNS were overall higher, up to 3-fold, compared with WT Cx32 expression. This is both due to higher expression in each oligodendrocyte, as shown by the increased number of Cx32 GJ plaques per cell compared with the Cx47KO (Fig. 7) , as well as due to the extra-physiological expression in all oligodendrocytes, such as those in the CC and optic nerves, in contrast to restricted Cx32 expression in specific subpopulations in WT CNS (11) . Plpdriven expression levels were higher compared with CNP-driven expression in previously generated mutants, reflecting the higher expression per cell, since CNP promoter also provided expression in all subsets of oligodendrocytes (7) .
There was no obvious adverse effect of Cx32 expression beyond the known subsets of oligodendrocytes, and these expression levels were sufficient to rescue the CNS phenotype of Cx32/Cx47dKO mice, similar to what has been achieved in the PNS using the P0 promoter transgene (20) . Interestingly, peripheral neuropathy was also rescued in this model, even with expression levels slightly below the WT levels, while P0
promoter-driven transgenic Cx32 expression levels in Schwann cells were much higher than WT levels (20) . The main goal of this project was to rescue the Cx32/ Cx47dKO leukodystrophy model by replacing one of the two missing oligodendrocyte connexins, in this case hCx32. Cx32/ Cx47dKO mice have been characterized in detail (12, 13) and provide a relevant model of hypomyelinating leukodystrophy offering an opportunity to study possible therapeutic interventions. In our hands, Cx32/Cx47dKO mice presented the previously reported phenotype of action tremor followed by tonic seizures during the fourth to fifth postnatal week, which increased in frequency and severity leading to death by the sixth postnatal week. Pathological analysis at 1 month of age showed the Oligodendrocyte GJs in TG + Cx32/Cx47dKO mice Our analysis of GJ formation in oligodendrocytes in TG + Cx32/ Cx47dKO mice revealed that Cx32 was extensively expressed along myelinated fibers, forming the homotypic intracellular channels, and also along fibers that normally express only Cx29, such as the CC and optic nerves (11, 14) . Furthermore, numerous Cx32 GJ plaques were formed around the cell bodies and were overall increased compared with Cx47KO mice, colocalizing mostly with Cx30 and to a much lesser degree with Cx43. Thus, transgenic replacement of Cx32 in the Cx32/Cx47dKO mouse appears to reestablish in part oligodendrocyte GJ connectivity, but does not replace Cx47 in O/A GJs, the majority of which are formed by Cx47 paired with Cx43 (10, 14, 17, 31) . Therefore, the TG + Cx32/Cx47dKO phenotype resembles that of Cx47KO mice. Even with the high levels of Cx32 expression achieved in all oligodendrocytes, Cx32 is likely to form only heterotypic O/A GJs with astrocytic Cx30, and homotypic O/O GJs with itself. This is in keeping with previous studies showing lack of coupling between transfected cells where one expresses Cx32 and the other Cx47 (15, 32) . Furthermore, Cx32 is unlikely to replace Cx47 in pairing with Cx43, since the available literature indicates that no functional Cx32/Cx43 channels can be formed (15, 32, 33) . Mice that lack Cx32 or express Cx32 mutants on Cx32KO background, such as T55I and R75W develop a progressive demyelinating peripheral neuropathy after 3 month of age (21) with subtle changes in the CNS myelin (7, 34) . Cx47KO mice show sporadic vacuolation of CNS myelinated fibers starting from the optic nerve. Myelination of the peripheral nerves is not affected by the deletion of Cx47 (12, 13) . In humans, unlike mice, loss of Cx47 function leads to PMLD or spastic paraparesis (1, 16) , while loss of Cx32 only rarely (35) , suggesting that Cx47 is more crucial for oligodendrocyte function and survival. Cx47 may play more important roles during development and oligodendrocyte differentiation and myelination (13): its expression in developing oligodendrocytes precedes those of Cx32 and Cx29 (36) . Moreover, oligodendrocytes throughout the CNS express Cx47 but only certain subpopulations express Cx32 (11, 14) .
Supporting these findings from rodent models, oligodendrocyte precursor cells in postmortem human brain studies were shown to express Cx47 but not Cx32, while mature oligodendrocytes express Cx47 throughout the human brain, similar to the expression pattern in rodents (37, 38) . Taken together, while our study provides the proof of principle for amelioration of phenotype by replacing-at least in part-GJ connectivity in oligodendrocytes in this PMLD model, it may be necessary to replace Cx47 in future clinical studies, since the presence of Cx32 in PMLD patients does not prevent the disease. Interestingly, a GJC2 mutation affecting O/O but not O/A GJ connectivity was found in a subclinical leukodystrophy patient (39) , indicating that even partial restoration of oligodendrocyte connectivity as described in our model may be sufficient to ameliorate the clinical phenotype, also in the human disease.
Why the loss of Cx47 is more detrimental for humans with PMLD as opposed to Cx47 KO mice is not clear, but may be related to several factors operating in humans that are not present in mice. Greater life span and brain size is a consideration, as well as stressful conditions that increase metabolic demand and requirements on GJ connectivity in oligodendrocytes, as also recognized for the CNS phenotypes resulting from Cx32 mutations (3, 35) . This metabolic stress occurs only under experimental conditions in laboratory mice and has indeed caused increased myelin vacuolation flowing increased axonal activity in Cx47 KO mice (40) . Another consideration is that Cx32/Cx30 channels can compensate for the loss of Cx47/ Cx43 channels in mice more effectively than in humans, although the overall distribution of glial connexin expression appears to be similar between human and rodent brain (11, 19, 37, 38) .
Oligodendrocyte connectivity to panglial network
Oligodendrocytes are closely connected to astrocytes via GJs. Both human disorders such as occulodental digital dysplasia syndrome resulting from GJA1/Cx43 mutations (41), as well as mouse models with astrocyte connexin deletions may cause demyelination, highlighting the importance of the panglial network connectivity for oligodendrocytes. Besides the Cx32/ Cx47dKO model, various other double connexin mutants including astrocytic connexins have sown similar phenotypes: The deletion of two astrocytic connexins in Cx30/Cx43 Astro dKO resulted in early onset vacuolation, edema, astrogliosis and oligodendrocyte apoptosis in the brain, as well as multiple behavioral deficits, although life span was normal (31, 42) . Overall, the WM abnormalities in these mutants resembled the ones in Cx32/Cx47dKO mice, but their milder phenotype highlighted the importance of O/O GJs (43, 44) that were preserved as opposed to the Cx32/ Cx47dKO.
Deletion of one astrocytic and one oligodendrocytic connexin proved to be more pathogenic than the loss of two astrocytic connexins, and resembled more the loss of two oligodendrocyte connexins. Cx32/Cx43 Astro KO mice (with mGFAP-cre driven deletion of Cx43) developed WM vacuolation by the fifth week and seizures by the eighth week with early mortality by 20 weeks (45). However, mGFAP-cre driven Cx43 Astro KO might have been incomplete and subsequent generation of another Cx32/Cx43 Astro dKO (with nestin-cre driven deletion of Cx43) resulting in complete deletion of Cx43 in astrocytes demonstrated loss of oligodendrocytes with demyelination and more phenotypic similarities to Cx32/Cx47dKO (46) . Furthermore, Cx47 expression in oligodendrocytes and stability on the cell membrane was shown to depend in the presence of Cx43 in astrocytes, indicating that in the Cx32/Cx43dKO Cx47:Cx30 O/A are also lost, and only homotypic O/O Cx47 GJs may be preserved, explaining the severity of the phenotype resembling Cx32/Cx47dKO. Likewise, Cx30/Cx47dKO mice showed early onset myelin pathology, severe vacuolation in the WM and activation of microglia and astrocytes, leading to early mortality (47) . As described in our study, this double mutant demonstrates that Cx32 cannot replace Cx47 in O/A GJs, but can only form channels with Cx30 in astrocytes. Overall, the results of glial connexin mutants highlight the importance of both O/O and O/A GJs for CNS myelination and homeostasis.
In conclusion, we show that the severe phenotype of the hypomyelinating leukodystrophy model with GJ-deficient oligodendrocytes can be rescued by replacement of one, in this case Cx32, oligodendrocyte connexins, by reestablishing, at least in part, the O/O and O/A connectivity. This study has implications for future therapeutic trials targeting CNS and PNS disorders resulting from connexin mutations, including PMLD and CMT1X.
Materials and Methods

Cloning of the transgenic construct
The transgenic construct was generated using the ∼11 kb mouse Plp promoter cloned in pBluescript SK+ vector (a gift from Prof. Karagogeos laboratory, University of Crete) previously used successfully to generate transgenic mice driving expression specifically in oligodendrocytes (24, (48) (49) (50) and downstream cloning of the human GJB1/Cx32 open reading frame (ORF) obtained from the pSLN1180 vector (7) . To have compatible sites with the MCS of the pBluescript SK+ vector, two new restriction sites, AscI and PacI, were introduced in pSLN1180 vector by PCR amplification using the following primers: AscI-F1 (5-′TACGCGTACG GCGCGCCCGCGGACA-3′) and PacI-R (5′CCTTAATTAAGGGGCG GATCCTCAGCAGGCCGAGCA-3′). The hCx32 ORF was isolated from pSLN1180 vector using AscI and PacI restriction enzymes, purified and ligated downstream of the PLP promoter in pBluescript SK+. Colonies were screened by PCR using two primer sets: Plp-F1 (5′-TGGGTGTTGGTTTTTGGAGA-3′) and Cx32-R (5-CGCTFTTGCAGCCAGGCTGG-3′) resulting in a 824 bp PCR product (94°C for 5 min 40 cycles of 94°C × 30 s, 60°C × 30 s, 72°C × 30 s and then 72°C for 7 min), as well as withPlp-F2 (5′CTGAG-TATTGTAGGCAAGGG-3′) and Cx32-R resulting in a 528 bp product. The transgenic cassette (PLP promoter with hCx32) (Fig. 1A) was then released from pBluescript SK+ by double digestion with ApaI and NotI. The ∼12 kb band was isolated and purified using Qiagen Gel extraction kit and finally eluted in microinjection buffer (Millipore, MR-095-F). The orientation and the in-frame positioning of the transgenic construct was further confirmed by direct sequencing analysis, including the entire ORF.
Animal strains and procedures
For this study we used C57BL/6 mice (Harlan Laboratories) for generation of transgenic lines, as well as Gjb1-null/Cx32 knockout (KO) mice (C57BL/6_129) (51) and Gjc2/Cx47 KO mice (C57BL/6;129P2/ OlaHsd) (13), both obtained from the European Mouse Mutant Archieve Monterotondo, Italy (originally generated by Prof. Klaus Willecke, University of Bonn). For all studies mice received anesthesia with intraperitoneal Avertin injection and then were either transcardially perfused and tissues were fixed for immunostaining analysis or electron microscopy, or tissues were removed unfixed for immunoblot and RNA analysis. All experimental procedures were conducted in accordance with the animal care protocols approved by the Cyprus Government's Chief Veterinary Officer according to EU guidelines (EC Directive 86/609/EEC).
Generation of transgenic mice expressing the WT human Cx32
The purified fragment was microinjected into the male pronucleus of fertilized oocytes obtained from C57BL/6 mice according to standard protocols at the Mouse Facility of the Cyprus Institute of Neurology and Genetics. After successful pregnancies and offspring delivery, founders were PCR screened by genomic tail DNA with specific primer sets for Plp promoter and Cx32 gene. Two primer sets were used for the promoter region ( proximal ligation site) and one for the distal ligation site to the multiple cloning site: (i) Plp-F1 and Cx32-R (as above) (ii) PlpF2 and Cx32-R (as above) and (iii) PlpMCS-F (5′-AGGTTTAAACAGTC GACTCTAG-3′) and Cx32-F2 (5′-GGCTCACCAGCAACACATAG-3′) resulting a 600 bp product (Fig. 1B) . Founders (TG + ) were bred with Gjb1-null/Cx32 KO mice in order to obtain mice expressing the transgene on a Cx32KO background (TG + Cx32KO).
Generation of TG + Cx32/Cx47dKO and Cx32/Cx47dKO mice Cx47KO mice were crossed with transgenic mice on a Cx32KO background (TG + Cx32KO). The mouse Cx47 coding region has been replaced with enhanced green fluorescent protein (EGFP) reporter gene in these mice. The Cx32 gene is located on the X chromosome and Cx47 gene is autosomal. F1 offspring was then crossed again to obtain males TG + Cx32KO/Cx47Het and Cx32KO/Cx47Het. Offspring of F2 generation were breed again to obtain TG + Cx32KO/Cx47dKO and Cx32KO/Cx47dKO. Cx32 genotype was tested by PCR screening using primers mentioned above. Cx47 genotype was screened by multiplex-PCR using simultaneously three primers. One primer is Cx47 intron-specific (P1-5′-CAGGATCAATGGAAGATTCTCGGTCCC-3′), the second is exon-specific (P3-5′-GCCAAGCGGTGGACTGCSTSGCCCAGG-3′) and the last EGFP-specific (P4) under conditions 95°C for 5 min 40 cycles of 94°C × 45 s, 64°C × 45 s, 72°C × 1 min and then 72°C for 7 min. A band at 530 bp represents the WT allele and at 340 bp the Cx47KO allele (13) (Fig. 1B) .
Reverse transcription PCR
Snap-frozen brain and spinal cord tissue from TG + Cx32KO, Cx32KO and WT mice were collected. RNA was isolated with the RNeasy Lipid Tissue Mini Kit (QIAGEN) following manufacturer's protocol. DNase treatment was performed and RNA was quantified by spectrophotometry. Of note, 0.5 μg of RNA was used to synthesize cDNA using Taqman Reverse transcription reagents (Applied Biosystems). cDNA was amplified using Cx32-F (5′-TGAGGCAGGATGAACTGGACAGGT-3′) and Cx32-R (5′-CAC GAAGCAGTCCACTGT-3′) primers. cDNA was then digested with MscI or HhaI as well as with both enzymes. MscI cuts the human cDNA into two fragments (280 and 273 bp); HhaI cuts the mouse cDNA product into two fragments (230 and 323 bp). Digestions were run on 1.5% agarose gel to estimate the relative levels of transgene/human and endogenous/mouse mRNAs (Fig. 1C) .
Immunoblot analysis
Fresh mouse tissues were collected and lysed in ice cold RIPA buffer (10 m sodium phosphate, pH 7.0, 150 m NaCl, 2 m EDTA, 50 m sodium fluoride, 1% NP-40, 1% sodium deoxycholate and 0.1% SDS) containing a cocktail protease inhibitors (Roche, Basel, Switzerland). Tissues were sonicated and protein concentrations were measured on NanoDrop. Fifty micrograms of protein from each tissue lysate were loaded into each well and fractioned by 12% SDS-PAGE gel. Then proteins were transferred to a Hybond-C extra membrane (GE Healthcare Bio-Sciences), using semidry transfer unit. Nonspecific sites on the membrane were blocked with 5% non-fat milk in Tris-buffered saline containing 0.1% Tween 20 (TBS-T) for 1 h (h) at room temperature (RT). Immunoblots were then incubated with rabbit antiserum against Cx32 (Clone 918, 1 : 5000; (18) in 5% milk and TBS-T, at 4°C overnight. After washing away excess primary antibody, immunoblots were incubated with anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antiserum (Jackson ImmunoResearch Laboratories, 1 : 3000) in 5% milk-TBS-T, for 1 h. GAPDH antibody (Santa Cruz, 1 : 4000) was then incubated on the same membranes and used as a loading control. The bound antibody was visualized by enhanced chemiluminescence system (ECL Plus, GE Healthcare Bio-Sciences, Amersham). Band intensity was measured and quantified using TinaScan software version 2.07d.
Immunohistochemistry
Following transcardial perfusion with 4% paraformaldehyde, brain, spinal cord, optic and sciatic nerves were post fixed for 30 min in the same fixative and then cryoprotected in 20% sucrose in 0.1  PB buffer overnight. Tissues were then embedded in OCT and placed in ice cold-acetone and stored in −80°C. Ten micrograms of thick sections were thaw-mounted onto glass slides. Tissues were permeabilized in cold acetone (−20°C) for 10 min and incubated at RT with blocking solution of 5% bovine serum albumin containing 0.5% Triton X-100 for 1 h followed by incubation overnight at 4°C with various combinations of primary antibodies: mouse anti-Cx32 
Quantitative analysis of pathology and GJ plaque formation
The fluorescent intensity of positive GFAP and IbaI from microscope pictures was calculated using ImageJ software. For quantification of GJ formation by oligodendrocytes, we randomly captured at least 20 individual oligodendrocytes within an area of 20 × 20 μm from spinal cord gray matter from three different mice per genotype. Pictures from the three genotypes were captured at ×400 magnification. The total number of Cx32, Cx30 and Cx43 GJ plaques in each image were counted using Adobe photoshop 6. In addition, we counted the number of GJ plaques in which Cx32 colocalized with either Cx30 or with Cx43 immunoreactivity and the overlap ratio was calculated in Microsoft Excel.
Electron microscopy and morphometric analysis
For electron microscopy, 1-month-old litters of G + Cx32/Cx47dKO
and Cx32/Cx47dKO mice (n = 4 per genotype) were transcardially perfused with 2.5% glutaraldehyde in 0.1  PB. Brain, spinal cord, optic nerve and sciatic nerve were dissected and further fixed overnight at 4°C, then osmicated, dehydrated and embedded in Araldite resin. Transverse semithin sections (1 μm) were obtained and stained with alkaline toluidine blue. Ultrathin sections (80-100 nm) were counterstained with lead citrate and uranyl acetate before being examined in a JEOL JEM-1010 transmission electron microscope. The CNS myelin fraction was calculated in semithin sections of the spinal cord dorsal and ventral funiculus and the optic nerve using a modified method to estimate the density of myelinated fibers and myelin sheaths (34, 52, 53) . Images of semithin sections captured at ×630 final magnification following the same processing and microscopy settings were imported into Photoshop (Adobe Systems) and a transparent counting grid was placed on the image. All intersections of the grid lines hitting WM, myelinated fibers and myelin sheaths were counted separately. The volume density of the myelinated fibers in the WM was calculated by the total number of points hitting myelinated fibers in the WM over the total number of points hitting WM.
Behavioral analysis
Foot slip test
To explore the motor behavior of mice a modified method of Britt (54) was used, which is considered sensitive for CNS demyelination models. One-month-old mice were placed in a 15 × 15 × 15 cm clear plexiglass box with a floor consisting of a metal wire grid with 1.25 cm spacing with a 1.25 cm grid suspended 1.25 cm above the floor. Mice were acclimated in the box for 1 h before each session. The trial consisted of 50 steps. If a misstep results in the hindlimb or forelimb falling through the grid but the limb is withdrawn prior to touching the floor is scored 1; if the limb touches the floor it is scored 2. A video camera was used to film the mice to ensure accurate counts, and video recordings were evaluated in slow motion. TG + Cx32/Cx47dKO mice were compared with Cx32/Cx47dKO littermates using the Student's t-test. Significance was defined as P < 0.05 in all comparisons.
Rotarod analysis
This apparatus consists of a computer-controlled, motor-driven rotating spindle and four lanes for four mice. One-month-old mice were habituated to the apparatus the first day for 180 s sessions twice at constant speeds of 12 and 20 rpm. The second day mice exert four trials with accelerating speed from 4 to 40 rpm. The mean latency to fall off the rotarod is calculated.
Foot print analysis
Footprints were obtained by painting the paws with nontoxic colored inks and the mouse was allowed to walk down a narrow, open-top runway covered with white paper. The runway length was 22 cm long 10 cm wide. Furthermore, the open-top runway was flanked by two walls at each side that were 11 cm high. The mice were acclimatized to the environment for at least 60 min, and were allowed two practice runs before coloring the paws. To facilitate subsequent analysis, forelimbs and hindlimbs were colored with different colors: blue for the front and red for the hindlimbs. Each mouse was subjected to a total of nine trials (three trials per day for 3 days). Once the footprints had dried, the following parameters were measured: overlap width, forelimb stride length, and hindlimb stride length for the left and right limbs separately.
Survival rates
The Kaplan-Meier survival curve was used to compare the survival rates of TG + Cx32/Cx47dKO with those of Cx32/Cx47dKO littermates. Two groups of 10 mice were used for this analysis and followed until they became severely ill and preterminal, but before they died of seizures. A graph was plotted for the percentage of surviving animals over time in weeks.
Supplementary Material
Supplementary Material is available at HMG online.
